The invention relates to the use of an EBV membrane antigen or derivative thereof in combination with a suitable adjuvant in the manufacture of a vaccine for the prevention of infectious mononucleosis (IM), and to vaccine compositions suitable for prevention of IM.
Bestmann, Hans Juergen; Schobert, Rainer, Angewandte Chemie, 1985, vol. 97, # 9, p. 784 - 785